Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal

Allergy and Asthma Proceedings 2026

View at publisher
Authors: Sema Koç Yıldırım, Ece ERBAĞCI, Neslihan Demirel Öğüt, Simge Ünal, Ece Gökyayla
DOI: 10.2500/aap.2026.47.250089
Cited by: 2
References: 33

Abstract

Background: There is currently no accepted biomarker for predicting which patients will experience relapse after discontinuation of omalizumab therapy. Objective: This retrospective study aimed to identify clinical and laboratory markers associated with chronic spontaneous urticaria relapse. Methods: “Relapse” was defined as a urticaria control test score of

Fields of Study & Subjects

Urticaria and Related Conditions Drug-Induced Adverse Reactions Psoriasis: Treatment and Pathogenesis

Publication details

Journal / source
Allergy and Asthma Proceedings
Publisher
Oceanside Publications Inc.
Volume
47
Issue
1
Pages
32–39
Publication date
1 January 2026
Language
EN